Schedule 13D ownership disclosure

ACELRX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00444T100

Event date: 2015-06-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-037705
Form type
SC 13D
Filer
TALPHERA, INC.
CIK
CIK 1427925
Filed
Jun 17, 2015
Reporting period
Jun 10, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub